Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARAY · against 1,335 other Healthcare companies
Ranked #782 of 1,336 · scores higher than 41% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 40–49, including ARAY · Click a bar to see the companies
A mix: stronger return on invested capital, but weaker operating margin and return on assets than most Healthcare peers.
| Metric | ARAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 10.7% | 4.7% | 69% | 33% | |
| Operating marginHigher is better · 1,251 reported | -2.6% | 7.1% | 31% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -1.4% | 1.7% | 36% | 33% | |
| Return on equityHigher is better · 1,252 reported | -80.1% | 3.2% | 9% | Context only | |
| Gross marginHigher is better · 1,394 reported | 27.7% | 45.9% | 30% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 782 | 1.8B CNY (≈$255M) | 41 | 29 | |
| 782 | 128.2B KRW (≈$92M) | 41 | 37 | |
| 782 | 63.5B JPY (≈$432M) | 41 | 57 | |
| 782 | 1.2B USD | 41 | 42 | |
| 782 | 17M USD | 41 | 16 | |
| 782 | 10.8B USD | 41 | 41 | |
| 782 | 1.1B CAD (≈$807M) | 41 | 60 | |
| 782 | 15.7B USD | 41 | 33 | |
| 782 | 4.0B USD | 41 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score